NCT00031811View on ClinicalTrials.gov

Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Breast CancerMenopausal SymptomsOsteoporosis
Interventions
DRUG

raloxifene

PROCEDURE

quality-of-life assessment

Trial Locations (1)

97201-3098

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT00031811 - Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer | Biotech Hunter | Biotech Hunter